Discovery of a Potent and Subtype-Selective Tyk2 Degrader Based on an Allosteric Tyk2 Inhibitor

被引：0
|
作者：
Kato, Jun-Ya [1 ]
Korenaga, Shigeru [2 ]
Iwakura, Masaru [1 ]
机构：
[1] Synthetic Research Department, ASKA Pharmaceutical Company Limited, 26-1 Muraoka-Higashi 2-Chome, Kanagawa, Fujisawa,251-8555, Japan
[2] Drug Discovery Department, ASKA Pharmaceutical Company Limited, 26-1 Muraoka-Higashi 2-Chome, Kanagawa, Fujisawa,251-8555, Japan
来源：
SSRN | 2022年
关键词：
Compilation and indexing terms; Copyright 2024 Elsevier Inc;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Amino acids - Enzymes
引用
收藏
相关论文
共 50 条
  • [31] Deucravacitinib is an allosteric TYK2 protein kinase inhibitor FDA-approved for the treatment of psoriasis
    Roskoski, Robert
    PHARMACOLOGICAL RESEARCH, 2023, 189
  • [32] Selective Tyrosine Kinase 2 (TYK2) Inhibition in Plaque Psoriasis
    Kircik, Leon
    Aldredge, Lakshi M.
    DiRuggiero, Douglas
    JOURNAL OF DRUGS IN DERMATOLOGY, 2024, 23 (08) : 645 - 652
  • [33] TYK2 as a novel therapeutic target in psoriasis
    Elyoussfi, Sarah
    Rane, Shraddha S.
    Eyre, Steve
    Warren, Richard B.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2023, 16 (06) : 549 - 558
  • [34] TYK2: An Upstream Kinase of STATs in Cancer
    Woess, Katharina
    Simonovic, Natalija
    Strobl, Birgit
    Macho-Maschler, Sabine
    Mueller, Mathias
    CANCERS, 2019, 11 (11)
  • [35] A New Patient with Inherited TYK2 Deficiency
    Sarrafzadeh, Shokouh Azam
    Mahloojirad, Maryam
    Casanova, Jean-Laurent
    Badalzadeh, Mohsen
    Bustamante, Jacinta
    Boisson-Dupuis, Stephanie
    Pourpak, Zahra
    Nourizadeh, Maryam
    Moin, Mostafa
    JOURNAL OF CLINICAL IMMUNOLOGY, 2020, 40 (01) : 232 - 235
  • [36] TYK2 in Immune Responses and Treatment of Psoriasis
    Shang, Lin
    Cao, Jiali
    Zhao, Siqi
    Zhang, Jingya
    He, Yanling
    JOURNAL OF INFLAMMATION RESEARCH, 2022, 15 : 5373 - 5385
  • [37] Tyk2 is a tumor suppressor in colorectal cancer
    Moritsch, Stefan
    Moedl, Bernadette
    Scharf, Irene
    Janker, Lukas
    Zwolanek, Daniela
    Timelthaler, Gerald
    Casanova, Emilio
    Sibilia, Maria
    Mohr, Thomas
    Kenner, Lukas
    Herndler-Brandstetter, Dietmar
    Gerner, Christopher
    Mueller, Mathias
    Strobl, Birgit
    Eferl, Robert
    ONCOIMMUNOLOGY, 2022, 11 (01):
  • [38] The hyper IgE syndrome and mutations in TYK2
    Woellner, Cristina
    Schaeffer, Alejandro A.
    Pluck, Jennifer M.
    Renner, Eleonore D.
    Knebel, Constanze
    Holland, Steve M.
    Plebani, Alessandro
    Grimbacher, Bodo
    IMMUNITY, 2007, 26 (05) : 535 - 535
  • [39] A New Patient with Inherited TYK2 Deficiency
    Shokouh Azam Sarrafzadeh
    Maryam Mahloojirad
    Jean-Laurent Casanova
    Mohsen Badalzadeh
    Jacinta Bustamante
    Stephanie Boisson-Dupuis
    Zahra Pourpak
    Maryam Nourizadeh
    Mostafa Moin
    Journal of Clinical Immunology, 2020, 40 : 232 - 235
  • [40] JAK Inhibitors for Treatment of Psoriasis: Focus on Selective TYK2 Inhibitors
    Miguel Nogueira
    Luis Puig
    Tiago Torres
    Drugs, 2020, 80 : 341 - 352
12345